The Finnish Faecal Microbiota Transplantation Study (FINFMT)

Launched by JOINT AUTHORITY FOR PÄIJÄT-HÄME SOCIAL AND HEALTH CARE · Nov 5, 2018

Keywords

ClinConnect Summary

The Finnish Faecal Microbiota Transplantation Study (FINFMT) is a clinical trial aimed at understanding the long-term effects of faecal microbiota transplantation (FMT). FMT is a treatment that involves transferring healthy bacteria from a donor's stool into a patient’s digestive system to help restore a healthy balance of gut bacteria. This study is open to adults over 18 years old who are receiving FMT for conditions like recurrent Clostridium difficile infection (rCDI) or other health issues. Participants will need to provide written consent and must not be involved in any other FMT trials.

If you join this study, researchers will monitor your health for up to ten years. This includes taking blood and stool samples for one year and completing questionnaires to track your progress and any potential side effects. The goal is to gather important information about how FMT affects people over time, which can help improve treatments for others in the future. Your participation could play a crucial role in advancing our understanding of gut health and FMT.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • \> 18 years age
• • receiving FMT for rCDI or any other madical condition
• • written consent
• • Not included in other FMT trials
• Exclusion Criteria:
• • Unable to provide written consent
• • \< 18 years age
• • Included in other FMT-trial